Naldi, L.; Fibbi, B.; Polvani, S.; Cirillo, C.; Pasella, F.; Bartolini, F.; Romano, F.; Fanelli, A.; Peri, A.; Marroncini, G.
The Vasopressin Receptor Antagonist Tolvaptan Counteracts Tumor Growth in a Murine Xenograft Model of Small Cell Lung Cancer. Int. J. Mol. Sci. 2024, 25, 8402.
https://doi.org/10.3390/ijms25158402
AMA Style
Naldi L, Fibbi B, Polvani S, Cirillo C, Pasella F, Bartolini F, Romano F, Fanelli A, Peri A, Marroncini G.
The Vasopressin Receptor Antagonist Tolvaptan Counteracts Tumor Growth in a Murine Xenograft Model of Small Cell Lung Cancer. International Journal of Molecular Sciences. 2024; 25(15):8402.
https://doi.org/10.3390/ijms25158402
Chicago/Turabian Style
Naldi, Laura, Benedetta Fibbi, Simone Polvani, Chiara Cirillo, Francesca Pasella, Francesca Bartolini, Francesca Romano, Alessandra Fanelli, Alessandro Peri, and Giada Marroncini.
2024. "The Vasopressin Receptor Antagonist Tolvaptan Counteracts Tumor Growth in a Murine Xenograft Model of Small Cell Lung Cancer" International Journal of Molecular Sciences 25, no. 15: 8402.
https://doi.org/10.3390/ijms25158402
APA Style
Naldi, L., Fibbi, B., Polvani, S., Cirillo, C., Pasella, F., Bartolini, F., Romano, F., Fanelli, A., Peri, A., & Marroncini, G.
(2024). The Vasopressin Receptor Antagonist Tolvaptan Counteracts Tumor Growth in a Murine Xenograft Model of Small Cell Lung Cancer. International Journal of Molecular Sciences, 25(15), 8402.
https://doi.org/10.3390/ijms25158402